Galazka A M, Robertson S E
Global Programme for Vaccines and Immunization, World Health Organization, Geneva, Switzerland.
Eur J Epidemiol. 1995 Feb;11(1):107-17. doi: 10.1007/BF01719955.
In the past, diphtheria was considered one of the most serious childhood diseases because it took a heavy toll in health and life among preschool-aged children. Prior to the widespread availability of diphtheria toxoid, nearly 70% of cases were in children younger than 15 years of age. In the industrialized countries, immunization against diphtheria became widespread in the 1940s and 1950s. This led to a marked decrease in the incidence of diphtheria. There was also a decrease in circulating toxigenic Corynebacterium diphtheriae organisms, resulting in less natural boosting of antibody levels. This had led to gaps in the immunity of the adult population. Since 1990, diphtheria has made a spectacular comeback in several European countries, with a high proportion of cases in adults. In developing countries, immunization of infants with diphtheria toxoid was introduced with the Expanded Programme on Immunization in the late 1970s. Coverage rose slowly to 46% in 1985 and 79% in 1992. Because the pool of immunized persons is not yet large, the process of maintaining immunity still operates through natural mechanisms, including frequent skin infections caused by C. diphtheriae. But recently, several developing countries where coverage has been high for 5-10 years have reported diphtheria outbreaks. These outbreaks have been characterized by high case fatality rates, a large proportion of patients with complications, and their occurrence in both young and older age groups. In all countries, priority should be given to efforts to reach at least 90% coverage with three doses of diphtheria toxoid in children below one year of age. In countries where diphtheria has been successfully controlled, immunity levels should be maintained by booster doses.
过去,白喉被认为是最严重的儿童疾病之一,因为它在学龄前儿童中造成了沉重的健康和生命损失。在白喉类毒素广泛供应之前,近70%的病例发生在15岁以下的儿童中。在工业化国家,20世纪40年代和50年代对白喉的免疫接种变得广泛。这导致白喉发病率显著下降。产毒白喉棒状杆菌的传播也有所减少,导致抗体水平的自然增强作用减弱。这导致了成年人群免疫力的差距。自1990年以来,白喉在几个欧洲国家惊人地卷土重来,成年病例占很大比例。在发展中国家,20世纪70年代末随着扩大免疫规划引入了对白喉类毒素的婴儿免疫接种。覆盖率在1985年缓慢上升至46%,1992年升至79%。由于免疫人群的规模仍然不大,维持免疫力的过程仍通过自然机制进行,包括白喉棒状杆菌引起的频繁皮肤感染。但最近,一些覆盖率在5至10年一直很高的发展中国家报告了白喉疫情。这些疫情的特点是病死率高、并发症患者比例大,且在青年和老年人群中均有发生。在所有国家,应优先努力使一岁以下儿童白喉类毒素三剂接种覆盖率至少达到90%。在白喉已成功得到控制的国家,应通过加强剂量维持免疫水平。